EGPAware: a European Delphi consensus study on red flags for suspicion of eosinophilic granulomatosis with polyangiitis
Abstract
Objectives: Diagnosing eosinophilic granulomatosis with polyangiitis (EGPA) is challenging due to its rarity, multisystem involvement, and varied clinical presentation, often resulting in delayed diagnoses and associated complications. EGPAware project aimed to establish a first European Delphi consensus on red flags for raising suspicion of EGPA to assist the prompt identification, referral, and diagnosis of these patients. Methods: EGPAware was a European Delphi study led by a multidisciplinary committee that developed the survey based on the red flags from a previously published Spanish systematic review and focused on clinical suspicion indicators. Data analysis used descriptive statistics, with consensus defined as ≥70% agreement. Statements with <70% consensus in the first round were revisited again in round 2. In the second round, panellists additionally ranked the 10 most relevant red flags by clinical importance and frequency of observation. Results: A multidisciplinary European group of 53 physicians with expertise in EGPA completed the 2-round Delphi survey. Consensus was reached on 25 red flags. Mononeuritis multiplex, lung infiltrates/nodules, vasculitis on biopsy, and myeloperoxidase-antineutrophil cytoplasmic antibodies positivity were the highest-ranked signs based on clinical relevance, whereas lung infiltrates/nodules, nasal polyposis, and mononeuritis multiplex were most frequently observed in panellists' experience. Conclusions: The EGPAware study provides a useful checklist of consensual red flags to be used in clinical practice to help clinicians identify patients with EGPA early. The study supports a multidisciplinary approach to EGPA diagnosis and management. Further research is recommended to refine diagnostic tools and validate these findings.
Related
- Angioimmunoblastic T-cell lymphoma mimicking eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
- Identification of EPX Variants in Human Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
- Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature
- Early recognition of eosinophilic granulomatosis with polyangiitis in outpatient settings: musculoskeletal and gastrointestinal clues beyond respiratory disease
- Case Report: Eosinophilic granulomatosis with polyangiitis presenting as a multiple sclerosis mimic
BibTeX
@article{hellmich2026egpaware,
title = {{EGPAware: a European Delphi consensus study on red flags for suspicion of eosinophilic granulomatosis with polyangiitis}},
author = {Bernhard Hellmich and Benjamin Terrier and Apostolos Bossios and Christian Domingo and Cristina Ponte and Roser Solans-Laque and Íñigo Rúa-Figueroa and Dimitrios Vassilopoulos and Gabriele Brembilla and Konstantina Kallinikou and Giacomo Emmi and Augusto Vaglio},
journal = {EULAR Rheumatology Open},
year = {2026},
month = nov,
doi = {10.1016/j.ero.2025.11.014},
url = {https://hal.science/hal-05864942v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - EGPAware: a European Delphi consensus study on red flags for suspicion of eosinophilic granulomatosis with polyangiitis
AU - Bernhard Hellmich
AU - Benjamin Terrier
AU - Apostolos Bossios
AU - Christian Domingo
AU - Cristina Ponte
AU - Roser Solans-Laque
AU - Íñigo Rúa-Figueroa
AU - Dimitrios Vassilopoulos
AU - Gabriele Brembilla
AU - Konstantina Kallinikou
AU - Giacomo Emmi
AU - Augusto Vaglio
PY - 2026
DA - 2026/11/15
JO - EULAR Rheumatology Open
DO - 10.1016/j.ero.2025.11.014
UR - https://hal.science/hal-05864942v1
AB - Objectives: Diagnosing eosinophilic granulomatosis with polyangiitis (EGPA) is challenging due to its rarity, multisystem involvement, and varied clinical presentation, often resulting in delayed diagnoses and associated complications. EGPAware project aimed to establish a first European Delphi consensus on red flags for raising suspicion of EGPA to assist the prompt identification, referral, and diagnosis of these patients. Methods: EGPAware was a European Delphi study led by a multidisciplinary committee that developed the survey based on the red flags from a previously published Spanish systematic review and focused on clinical suspicion indicators. Data analysis used descriptive statistics, with consensus defined as ≥70% agreement. Statements with <70% consensus in the first round were revisited again in round 2. In the second round, panellists additionally ranked the 10 most relevant red flags by clinical importance and frequency of observation. Results: A multidisciplinary European group of 53 physicians with expertise in EGPA completed the 2-round Delphi survey. Consensus was reached on 25 red flags. Mononeuritis multiplex, lung infiltrates/nodules, vasculitis on biopsy, and myeloperoxidase-antineutrophil cytoplasmic antibodies positivity were the highest-ranked signs based on clinical relevance, whereas lung infiltrates/nodules, nasal polyposis, and mononeuritis multiplex were most frequently observed in panellists' experience. Conclusions: The EGPAware study provides a useful checklist of consensual red flags to be used in clinical practice to help clinicians identify patients with EGPA early. The study supports a multidisciplinary approach to EGPA diagnosis and management. Further research is recommended to refine diagnostic tools and validate these findings.
SN - 3050-7081
SN - 3050-7081
ER -